{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"9.4","upperLimit":"12.4","value":"10.8"},{"groupId":"OG001","lowerLimit":"7.7","upperLimit":"9.9","value":"9.2"},{"groupId":"OG002","lowerLimit":"7.2","upperLimit":"8.9","value":"7.5"},{"groupId":"OG003","lowerLimit":"7.7","upperLimit":"9.5","value":"9.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"325"},{"groupId":"OG001","value":"331"},{"groupId":"OG002","value":"221"},{"groupId":"OG003","value":"219"}],"units":"Participants"}],"description":"Time to progression was defined as time from randomization date to date of disease progression per the modified RECIST criteria.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants with wild-type KRAS were randomized to panitumumab, 6 mg/kg on Day 1 and FOLFOX chemotherapy regimen on Days 1 and 2 of each 14-day cycle until disease progression or unacceptable toxicity.","id":"OG000","title":"Wild-type KRAS - FOLFOX + Panitumumab"},{"description":"Participants with wild-type KRAS were randomized to FOLFOX chemotherapy regimen on Days 1 and 2 of each 14-day cycle until disease progression or until unacceptable toxicity.","id":"OG001","title":"Wild-type KRAS - FOLFOX"},{"description":"Participants with mutant KRAS were randomized to panitumumab, 6 mg/kg on Day 1 and FOLFOX chemotherapy regimen on Days 1 and 2 of each 14-day cycle until disease progression or unacceptable toxicity.","id":"OG002","title":"Mutant KRAS - FOLFOX + Panitumumab"},{"description":"Participants with mutant KRAS were randomized to FOLFOX chemotherapy regimen on Days 1 and 2 of each 14-day cycle until disease progression or until unacceptable toxicity.","id":"OG003","title":"Mutant KRAS - FOLFOX"}],"paramType":"MEDIAN","populationDescription":"KRAS Efficacy Analysis Set","reportingStatus":"POSTED","timeFrame":"From randomization until the data cut-off date of 30 September 2008; Maximum follow-up time was 109 weeks.","title":"Time to Progression","type":"SECONDARY","unitOfMeasure":"months"}